ABSTRACT
Neuropathic pain is one of the common complications of diabetes. Tetrahydropalmatine(THP) is a main active component of Corydalis Rhizoma with excellent anti-inflammatory and pain-alleviating properties. This study aims to investigate the therapeutic effect of THP on diabetic neuropathic pain(DNP) and the underlying mechanism. High-fat and high-sugar diet(4 weeks) and streptozotocin(STZ, 35 mg·kg~(-1), single intraperitoneal injection) were employed to induce type-2 DNP in rats. Moreover, lipopolysaccharide(LPS) was used to induce the activation of BV2 microglia in vitro to establish an inflammatory cellular model. Fasting blood glucose(FBG) was measured by a blood glucose meter. Mechanical withdrawal threshold(MWT) was assessed with von Frey filaments, and thermal withdrawal latency(TWL) with hot plate apparatus. The protein expression levels of OX42, inducible nitric oxide synthase(iNOS), CD206, p38, and p-p38 were determined by Western blot, the fluorescence expression levels of OX42 and p-p38 in the dorsal horn of the rat spinal cord by immunofluorescence, the mRNA content of p38 and OX42 in rat spinal cord tissue by qRT-PCR, and levels of nitric oxide(NO), interleukin-1β(IL-1β), interleukin-6(IL-6), tumor necrosis factor-α(TNF-α), interleukin-10(IL-10), and serum fasting insulin(FINS) by enzyme-linked immunosorbent assay(ELISA). RESULTS:: showed that the mo-del group demonstrated significant decrease in MWT and TWL, with pain symptoms. THP significantly improved the MWT and TWL of DNP rats, inhibited the activation of microglia and p38 MAPK signaling pathway in rat spinal cord, and ameliorated its inflammatory response. Meanwhile, THP promoted the change of LPS-induced BV2 microglia from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype, suppressed the activation of the p38 MAPK signaling pathway, decreased the expression levels of inflammatory factors NO, IL-1β, IL-6, and TNF-α, and increased the expression level of anti-inflammatory factor IL-10. The findings suggested that THP can significantly ameliorate the pain symptoms of DNP rats possibly by inhibiting the inflammatory response caused by M1 polarization of microglia via the p38 MAPK pathway.
Subject(s)
Animals , Berberine Alkaloids , Blood Glucose/metabolism , Diabetes Mellitus , Diabetic Neuropathies/genetics , Interleukin-10 , Interleukin-6/metabolism , Lipopolysaccharides/pharmacology , Microglia , Neuralgia/metabolism , Rats , Rats, Sprague-Dawley , Signal Transduction , Spinal Cord/metabolism , Streptozocin/therapeutic use , Tumor Necrosis Factor-alpha/metabolism , p38 Mitogen-Activated Protein Kinases/metabolismABSTRACT
Abstract Background and aim: Stingless bee propolis, a resinous compound processed by mandibular secretion of stingless bees, is used for maintenance of hygiene and stability of beehives. Research on stingless bee propolis shows therapeutic properties attributed to polyphenols exhibiting antioxidative, antihyperglycemic and antiischemic effect. However, the cardioprotective effect of stingless bee propolis on diabetic cardiomyopathy is unknown. Methods: Adult male Sprague Dawley rats were randomised to five groups: normal group, diabetic group, diabetic given metformin (DM+M), diabetic given propolis (DM+P) and diabetic given combination therapy (DM+M+P) and treated for four weeks. Body weight, fasting blood glucose, food and water intake were taken weekly. At the end of experiment, biomarkers of oxidative damage were measured in serum and heart tissue. Antioxidants in heart tissue were quantified. Part of left ventricle of heart was processed for histological staining including Haematoxylin and Eosin (H&E) stain for myocyte size and Masson's Trichrome (MT) stain for heart fibrosis and perivascular fibrosis. Results: Propolis alleviated features of diabetic cardiomyopathy such as myocyte hypertrophy, heart fibrosis and perivascular fibrosis associated with improvement in antioxidative status. Conclusion: This study reports beneficial effect of propolis and combination with metformin in alleviating histopathological feature of diabetic cardiomyopathy by modulating antioxidants, making propolis an emerging complementary therapy.
Subject(s)
Animals , Male , Rats , Propolis/adverse effects , Bees/classification , Diabetic Cardiomyopathies/pathology , Staining and Labeling/instrumentation , Blood Glucose/metabolism , Rats, Sprague-Dawley/classification , Cardiomegaly/pathology , Eosine Yellowish-(YS) , Drinking , Heart Ventricles/abnormalities , Hypoglycemic Agents , Metformin/agonists , Antioxidants/adverse effectsABSTRACT
Objective: To analyze the effect of psychological suggestion combined with rational food restriction therapy on blood glucose, lipid metabolism and mental resilience in patients with diabetes. Methods: Patients with diabetes admitted to the Third Hospital of Nanchang from January 2020 to August 2020 were divided into the control group and the intervention group with randomized controlled and single blind methods. The control group was treated with routine dietary guidance and health education, and the intervention group was treated with psychological suggestion combined with rational diet therapy on the basis of the control group. Both groups were treated for 3 months. Blood glucose, lipid metabolism, mental resilience and quality of life were compared between the two groups at baseline and after 3-month intervention. Differences between groups and within groups were analyzed by t test and χ2 test. Results: 100 patients in the control group and 81 patients in the intervention group completed 3-month intervention. After 3-month intervention, the levels of glycosylated hemoglobin, fasting blood glucose, 2-hour postprandial blood glucose, low-density lipoprotein cholesterol and triglyceride in both groups were lower than those before intervention. The levels of these indicators in intervention group were lower than those in control group (P<0.05). However, the levels of high-density lipoprotein cholesterol and the scores of tenacity, self-reliance, optimism, role function, emotional function, social function, physical function and cognitive function in both groups were higher than those before intervention. These indicators in intervention group were higher than those in control group (P<0.05). Conclusion: Psychological suggestion combined with rational food restriction therapy could effectively improve the glucose and lipid metabolism, mental resilience, and quality of life among patients with diabetes.
Subject(s)
Blood Glucose/metabolism , Diabetes Mellitus, Type 2 , Humans , Lipid Metabolism , Quality of Life , Single-Blind MethodABSTRACT
The synthesis and decomposition of glycogen adjust the blood glucose dynamically to maintain the energy supply required by the cells. As the only hormone that lowers blood sugar in the body, insulin can promote glycogen synthesis by activating the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and increasing glucose transporter translocation, and inhibit gluconeogenesis to lower blood glucose. In the endometrium, glycogen metabolism is active, but gluconeogenesis does not occur. The glycogen metabolism in the endometrium is controlled not only by the classical glucose regulating hormones, but also by the ovarian hormones. The functional activities related to implantation of the endometrium during the implantation window require glucose as energy source. A large amount of glucose is used to synthesize glycogen in the endometrium before implantation, which could meet the increased energy demand for embryo implantation. In diabetes, glycogen metabolism in the endometrium is impaired, which frequently leads to implantation failure and early abortion. This article reviews the glycogen metabolism in the endometrium and discusses its role in embryo implantation, which provide new ideas for embryo implantation research and infertility treatment.
Subject(s)
Blood Glucose/metabolism , Embryo Implantation , Endometrium , Female , Glucose/metabolism , Glycogen/metabolism , Humans , Insulin/metabolism , Phosphatidylinositol 3-Kinases/metabolism , PregnancyABSTRACT
BACKGROUND@#Gestational diabetes mellitus (GDM) brings health issues for both mothers and offspring, and GDM prevention is as important as GDM management. It was shown that a history of GDM was significantly associated with a higher maternal risk for GDM recurrence. The incidence of GDM recurrence was unclear because of the incidence of second-child was low before 2016 in China. We aim to investigate the prevalence of GDM recurrence and its associated high-risk factors which may be useful for the prediction of GDM recurrence in China.@*METHODS@#A retrospective study was conducted which enrolled participants who underwent regular prenatal examination and delivered twice in the same hospital of 18 research centers. All participants were enrolled from January 2018 to October 2018, where they delivered the second baby during this period. A total of 6204 women were enrolled in this study, and 1002 women with a history of GDM were analyzed further. All participants enrolled in the study had an oral glucose tolerance test (OGTT) result at 24 to 28 weeks and were diagnosed as GDM in the first pregnancy according to the OGTT value (when any one of the following values is met or exceeded to the 75-g OGTT: 0 h [fasting], ≥5.10 mmol/L; 1 h, ≥10.00 mmol/L; and 2 h, ≥8.50 mmol/L). The prevalence of GDM recurrence and development of type 2 diabetes mellitus were calculated, and its related risk factors were analyzed.@*RESULTS@#In 6204 participants, there are 1002 women (1002/6204,16.15%) with a history of GDM and 5202 women (5202/6204, 83.85%) without a history of GDM. There are significant differences in age (32.43 ± 4.03 years vs. 33.00 ± 3.34 years vs. 32.19 ± 3.37 years, P < 0.001), pregnancy interval (4.06 ± 1.44 years vs. 3.52 ± 1.43 years vs. 3.38 ± 1.35 years, P = 0.004), prepregnancy body mass index (BMI) (27.40 ± 4.62 kg/m2vs. 23.50 ± 3.52 kg/m2vs. 22.55 ± 3.47 kg/m2, P < 0.001), history of delivered macrosomia (22.7% vs. 11.0% vs. 6.2%, P < 0.001) among the development of diabetes mellitus (DM), recurrence of GDM, and normal women. Moreover, it seems so important in the degree of abnormal glucose metabolism in the first pregnancy to the recurrence of GDM and the development of DM. There are significant differences in OGTT levels of the first pregnancy such as area under the curve of OGTT value (18.31 ± 1.90 mmol/L vs. 16.27 ± 1.93 mmol/L vs. 15.55 ± 1.92 mmol/L, P < 0.001), OGTT fasting value (5.43 ± 0.48 mmol/L vs. 5.16 ± 0.49 mmol/L vs. 5.02 ± 0.47 mmol/L, P < 0.001), OGTT 1-hour value (10.93 ± 1.34 mmol/L vs. 9.69 ± 1.53 mmol/L vs. 9.15 ± 1.58 mmol/L, P < 0.001), OGTT 2-hour value (9.30 ± 1.66 mmol/L vs. 8.01 ± 1.32 mmol/L vs. 7.79 ± 1.38 mmol/L, P < 0.001), incidence of impaired fasting glucose (IFG) (fasting plasma glucose ≥5.6 mmol/L) (31.3% vs. 14.6% vs. 8.8%, P < 0.001), and incidence of two or more abnormal OGTT values (68.8% vs. 39.7% vs. 23.9%, P < 0.001) among the three groups. Using multivariate analysis, the factors, such as age (1.07 [1.02-1.12], P = 0.006), prepregnancy BMI (1.07 [1.02, 1.12], P = 0.003), and area under the curve of OGTT in the first pregnancy (1.14 [1.02, 1.26], P = 0.02), have an effect on maternal GDM recurrence; the factors, such as age (1.28 [1.01-1.61], P = 0.04), pre-pregnancy BMI (1.26 [1.04, 1.53], P = 0.02), and area under the curve of OGTT in the first pregnancy (1.65 [1.04, 2.62], P = 0.03), have an effect on maternal DM developed further.@*CONCLUSIONS@#The history of GDM was significantly associated with a higher maternal risk for GDM recurrence during follow-up after the first pregnancy. The associated risk factors for GDM recurrence or development of DM include age, high pre-pregnancy BMI, history of delivered macrosomia, the OGTT level in the first pregnancy, such as the high area under the curve of OGTT, IFG, and two or more abnormal OGTT values. To prevent GDM recurrence, women with a history of GDM should do the preconception counseling before preparing next pregnancy.
Subject(s)
Adult , Blood Glucose/metabolism , China/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Diabetes, Gestational , Female , Fetal Macrosomia , Glucose Intolerance , Humans , Male , Pregnancy , Retrospective StudiesABSTRACT
Los autores de este artículo abordan la evidencia disponible sobre la prevención de diabetes tipo 2 mediante la indicación de metformina en pacientes sin alteraciones de la glucemia, a partir de una consulta de la práctica ambulatoria. (AU)
The authors of this article discuss the available evidence on the prevention of type 2 diabetes through the prescription of metformin to patients without glycemic alterations, based on an outpatient practice consultation. (AU)
Subject(s)
Humans , Male , Adult , Primary Prevention , Diabetes Mellitus, Type 2/prevention & control , Metformin/therapeutic use , Blood Glucose/metabolism , Risk Factors , Disease Progression , Ambulatory Care , Life Style , Metformin/administration & dosageABSTRACT
Diabetic patients are at risk of developing unfavorably from SARS-COV19 disease, especially when they have poor glycemic control. On the other hand, in the case of diabetic patients with severe COVID, they evolve with severe hyperglycemia, often difficult to manage. Marked hyperglycemia has also been described in people without a known history of previous diabetes, even there have been reported cases of insulin-dependent diabetes debut in days after the disease. The aim of this review is to analyze possible mechanisms involved in the relationship between COVID-19 and DIABETES.
Subject(s)
Humans , Diabetes Mellitus/epidemiology , COVID-19/epidemiology , Hyperglycemia/complications , Prognosis , Blood Glucose/metabolism , Diabetes Mellitus/physiopathology , COVID-19/physiopathology , COVID-19/virology , Hospitalization/statistics & numerical data , Hyperglycemia/physiopathologyABSTRACT
Introducción: La diabetes mellitus se considera un síndrome heterogéneo con etiología compleja en el que influyen factores genéticos y ambientales. Objetivo: Identificar la presencia de alteraciones del metabolismo glucídico y factores de riesgo aterogénicos en familiares de primera línea de pacientes diabéticos tipo 2. Métodos: Se realizó un estudio descriptivo de corte transversal que incluyó a 120 pacientes adultos, hijos de pacientes diabéticos, en los que no se encontraban antecedentes de alteraciones del metabolismo glucídico, pertenecientes al Policlínico Universitario Héroes del Moncada, del municipio Plaza de la Revolución. Se estudiaron variables sociodemográficas, variables clínicas y relacionadas con los estilos de vida como la tensión arterial, el índice de masa corporal, colesterol, triglicéridos, glucemias (ayunas y posprandial), hábito de fumar, actividad física y hábitos dietéticos. Resultados: Los pacientes tenían una edad promedio de 54,42 años y predominó el sexo femenino. Se detectaron alteraciones del metabolismo glucídico en 28,3 por ciento de los cuales 23,3 por ciento se consideraron prediabéticos y 5 por ciento diabéticos. Los factores de riesgo que predominaron fueron la dieta inadecuada, obesidad abdominal, hipercolesterolemia e hipertrigliceridemia que fueron más evidentes en los pacientes diagnosticados como diabéticos. Conclusiones: Los familiares de primer grado de pacientes diabéticos pueden presentar una alta prevalencia de alteraciones del metabolismo glucídico y factores de riesgo aterogénicos, aún sin sintomatología evidente, lo que refuerza la necesidad de realizar un diagnóstico temprano para evitar la progresión de la enfermedad(AU)
Introduction: Diabetes mellitus is considered a heterogeneous syndrome with a complex etiology, influenced by genetic and environmental factors. Objective: To identify the presence of alterations of the glucidic metabolism and atherogenic risk factors in first- degree relatives of type 2 diabetic patients. Methods: A descriptive cross-sectional study was carried out at Heroes del Moncada University Polyclinic, in Plaza de la Revolution municipality. The study included 120 adult patients, descendants of diabetic patients. They had no history of alterations of the glucidic metabolism. Sociodemographic, clinical variables were studied, and those related to lifestyles such as blood pressure, body mass index, cholesterol, triglycerides, (fasting and postprandial) glycaemia, smoking, physical activity and dietary habits. Results: These patients had average age of 54.42 years and the female sex predominated. Alterations of the glucidic metabolism were detected in 28.3 percent, 23.3 percent of them were considered pre-diabetic and 5 percent diabetic. The predominant risk factors were inadequate diet, abdominal obesity, hypercholesterolemia, and hypertriglyceridemia, which was much evident in patients diagnosed as diabetic. Conclusions: The first-degree relatives of diabetic patients may present high prevalence of alterations of glucidic metabolism and atherogenic risk factors, even with no evident symptoms, which reinforces the need of early diagnosis to avoid the progression of the disease(AU)
Subject(s)
Humans , Male , Female , Blood Glucose/genetics , Blood Glucose/metabolism , Family , Epidemiology, Descriptive , Cross-Sectional Studies , Health Risk , Diabetes Mellitus/metabolism , Diabetes Mellitus, Type 2/geneticsABSTRACT
RESUMO Objetivo: avaliar as diferenças no perfil metabonômico de pacientes que atingiram remissão de diabetes mellitus tipo 2 (DM2) após cirurgia bariátrica em relação aos que apresentaram manutenção ou recidiva dessa condição após a cirurgia. Métodos: Participaram do estudo 33 pacientes obesos diabéticos tipo 2, dos quais 22 tiveram remissão completa da DM2 e 11 tiveram recidiva da DM2 ou não apresentaram remissão da doença no pós-operatório. Amostras de sangue foram coletadas para avaliação dos perfis metabonômicos séricos através de um estudo metabonômico baseado em RMN de 1H. Resultados: o modelo metabonômico para avaliação da recidiva da diabetes apresentou uma acurácia de 93,9%, sensibilidade de 81,8%, especificidade de 100%, valor preditivo positivo (VPP) igual a 100% e valor preditivo negativo (VPN) igual a 91,7%. Conclusão: a cirurgia bariátrica promove efeitos específicos na distribuição dos metabólitos de pacientes que atingiram remissão de DM2, e essa nova distribuição pode ser avaliada através de um modelo metabonômico.
ABSTRACT Purpose: To evaluate the differences in the metabonomic profile of patients who achieved remisison of Type 2 diabetes mellitus (T2DM) after bariatric surgery in relation to those who presented maintenance or recurrence of this condition after surgery. Methods: Thirthy-three patients with obesity and T2D were submitted to bariatric/metabolic surgery, among which, 22 experienced complete remission of T2D, and 11 did not experience remission in the postoperative period. Blood samples were taken in order to assess the serum profiles through a 1H NMR-based metabonomic study. Results: The metabonomic model for the assessment of T2D recurrence presented an accuracy of 93.9%, sensibility of 81.8%, specificity of 100%, positive predictive value of 100% and a negative predictive value of 91.7%. Conclusion: bariatric surgery provide specific effects on the distribution of metabolites in those patients who achieved remission of T2DM, and this new distribution can be assessed through a metabonomic model.
Subject(s)
Humans , Male , Female , Obesity, Morbid/surgery , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/metabolism , Bariatric Surgery , Time Factors , Blood Glucose/metabolism , Obesity, Morbid/metabolism , Remission Induction , Biomarkers/metabolism , Weight Loss , Cross-Sectional Studies , Predictive Value of Tests , Sensitivity and Specificity , Treatment Outcome , Middle AgedABSTRACT
The consumption of alcoholic beverages influences carbohydrate and lipid metabolism, although it is not yet clear whether metabolism during physical exercise at different intensities is also affected. This was the objective of the present study. Eight young and healthy volunteers performed a treadmill test to identify the running speed corresponding to a lactate concentration of 4 mM (S4mM). At least 48 h later, they were subjected to two experimental trials (non-alcohol or alcohol) in which they performed two 1-km running sessions at the following intensities: 1) S4mM; 2) 15% above S4mM. In both trials, blood lactate, triglycerides, and glucose concentrations were measured before and after exercise. The acute alcohol intake increased triglycerides, but not lactate concentration under resting conditions. Interestingly, alcohol intake enhanced the exercise-induced increase in lactate concentration at the two intensities: S4mM (non-alcohol: 4.2±0.3 mM vs alcohol: 4.8±0.9 mM; P=0.003) and 15% above S4mM trial (P=0.004). When volunteers ingested alcohol, triglycerides concentration remained increased after treadmill running (e.g., at S4mM - at rest; non-alcohol: 0.2±0.5 mM vs alcohol: 1.3±1.3 mM; P=0.048). In contrast, glucose concentration was not modified by either alcohol intake, exercise, or their combination. We concluded that an acute alcohol intake changed lactate and lipid metabolism without affecting blood glucose concentration. In addition, the increase in lactate concentration caused by alcohol was specifically observed when individuals exercised, whereas augmented triglycerides concentration was already observed before exercise and was sustained thereafter.
Subject(s)
Humans , Male , Adult , Young Adult , Physical Endurance/drug effects , Blood Glucose/metabolism , Alcohol Drinking/blood , Lactic Acid/blood , Ethanol/metabolism , Alcoholic Beverages/analysis , Physical Endurance/physiology , Triglycerides/blood , Blood Glucose/analysis , Exercise Test , Athletic Performance/physiologyABSTRACT
Objetivo: Relacionar a evoluçaÌo do perfil lipiÌdico, gliceÌmico e pressoÌrico de prematuro do nascimento aos 2 anos de idade corrigida com a classificaçaÌo de peso ao nascer e sexo. Metodologia: Estudo longitudinal, amostra inicial de 71 prematuros, destes, 31 completaram o acompanhamento ambulatorial. Avaliados ao nascer, alta, 6 meses e 2 anos de idade corrigida (peso, idade gestacional, perfil lipiÌdico, gliceÌmico, pressaÌo arterial). Resultados: Glicemia, colesterol total, pressaÌo arterial e trigliceriÌdeos, naÌo foram estatisticamente significantes em relaçaÌo ao peso ao nascer e ao longo do seguimento. Colesterol total (p=0,18) e glicemia sofreram efeito de interaçaÌo com o sexo. PressaÌo arterial acima do esperado aos 2 anos. Crescimento foi uniforme independente do sexo. ConclusaÌo: O perfil lipiÌdico, gliceÌmico e pressoÌrico dos prematuros ao longo do acompanhamento naÌo foi influenciado pela classificaçaÌo de peso ao nascer. O sexo influenciou as concentraçoÌes de colesterol e a glicemia.
Objective: To relate the evolution of the lipid, glycemic and blood pressure profile of premature infants from birth to 2 years corrected age with the classification of birth weight and sex. Methodology: Longitudinal study, initial sample of 71 premature infants, of which 31 completed outpatient follow-up. Evaluated at birth, discharge, 6 months and 2 years corrected age (weight, gestational age, lipid, glycemic, blood pressure profile). Results: Blood glucose, total cholesterol, blood pressure and triglycerides were not statistically significant in relation to birth weight nor throughout follow-up. Total cholesterol (p=0.18) and blood glucose underwent interaction with sex. Blood pressure was higher than expected at 2 years old. Growth was uniform regardless of sex. Conclusion: The lipid, glycemic and blood pressure profile of premature infants during follow-up was not influenced by the birth weight classification. The cholesterol and blood glucose concentrations were influenced by sex.
Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Infant, Premature , Continuity of Patient Care , Lipid Metabolism , Blood Glucose/metabolism , Neonatal Nursing , Arterial PressureABSTRACT
Introdução: A associação entre perda auditiva e Diabetes Mellitus tipo 1 (DM1) é ainda pouco estudada. A perda auditiva é uma das complicações crônicas relacionadas ao grau de controle glicêmico, que os pacientes podem apresentar com a progressão da doença. Objetivo: Investigar o comprometimento auditivo por meio das emissões otoacústicas transitórias (EOAT) por banda de frequência em adolescentes com DM1 e relação com o controle glicêmico. Métodos: Foram incluídos 80 adolescentes, 50% do gênero masculino, entre 10 e 19 anos de idade: 40 com DM1 e 40 controles saudáveis, pareados por gênero e idade. Os dados clínicos e laboratoriais foram pesquisados nos prontuários médicos. O controle glicêmico foi avaliado por meio dos exames de hemoglobina glicada e os pacientes com DM1 analisados de acordo com o controle glicêmico. A avaliação auditiva foi realizada por meio da imitanciometria, audiometria, e posteriormente EOAT, em sala tratada acusticamente, pelo protocolo "TE Test" de clique não-linear (1 KHz a 4 kHz) a 80 dB NPS de intensidade (AuDX - Biologic). Resultados: As respostas às EOAT foram ausentes em 5,12% em pacientes com DM1, com diferença significativa em relação aos controles (p=0,04). A análise das EOAT por bandas de frequência mostrou maior proporção de alteração nos adolescentes com DM1 mal controlados quando comparados aos bem controlados, nas frequências de 1000Hz, 2000Hz e 3000Hz (p<0,05). Conclusão: As EOAT por bandas de frequência permitiram a identificação precoce de comprometimento auditivo em adolescentes com DM1 e mostraram associação entre DM1 mal controlado e perda auditiva. (AU)
Introduction: The association between hearing loss and type 1 diabetes mellitus (DM1) is still poorly studied. Hearing loss is one of the chronic complications related to the degree of glycemic control that patients may present with the progression of the disease. Objective: To investigate auditory impairment through transient otoacoustic emissions (TEOAE) by frequency band in adolescents with DM1 and in relation to glycemic control. Methods: Were included 80 adolescents, 50% males, between 10 and 19 years of age: 40 with DM1 and 40 healthy controls, matched by gender and age. Clinical and laboratory data were taken from the medical records. Glycemic control was evalueted by glycated hemoglobin and the patients with DM1 were analyzed according to glycemic control. To the auditory evaluation were used the immittance and audiometry, and the TEOAE. The test was performed in the acoustically treated room, the non-linear TE test protocol (1 KHz to 4 kHz) at 80 dB SPL (AuDX - Biologic ). Results: TEOAE responses were absent in 5.12% of patients with DM1, with a significant difference in relation to controls (p = 0.04). The analysis of TEOAE by frequency bands showed a higher proportion of alteration in adolescents with DM1 poorly controlled when compared to well controlled ones, in the frequencies of 1000Hz, 2000Hz and 3000Hz (p <0.05). Conclusion: TEOAE by frequency bands allowed the early identification of auditory impairment in adolescents with DM1 and showed an association between poorly controlled DM1 and hearing loss. (AU)
Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Young Adult , Acoustic Stimulation/methods , Diabetes Mellitus, Type 1/physiopathology , Blood Glucose/metabolism , Case-Control Studies , Cross-Sectional Studies , Cochlea , Diabetes Mellitus, Type 1/complications , Hearing Loss/etiology , Hearing Tests/methodsABSTRACT
Introdução: os padrões referentes à glicemia não foram descritos e explicados utilizando-se uma teoria de enfermagem como referencial, nem tão pouco articulados e modelados às estruturas preditoras de interesse para ação da enfermagem diante destas condições. Sendo assim, presume-se a relevância de construir uma teoria de médio alcance que aborde os fatores predisponentes e precipitantes para os padrões de variabilidade relativos à glicemia, explicando relações e predizendo associações que possam suportar o julgamento diagnóstico de enfermagem para a população com diabetes mellitus em tratamento. Objetivo: desenvolver uma teoria de médio alcance sobre variações glicêmicas em adultos e idosos com diabetes mellitus em tratamento tendo por base o Modelo Conceitual da Adaptação de Roy. Método: pesquisa teórica do tipo desenvolvimento de uma nova teoria. Para teorização utilizou-se a proposta de processo geral de pesquisa de Holton e Lowe (2007). Os procedimentos metodológicos desenvolvidos foram implementados em três partes: parte 1 a) entendimento dos fenômenos; b) identificação e recuperação dos estudos na revisão sistemática de etiologia e risco e análise do modelo de adaptação de Roy; c) análise do construto; parte 2 d) identificação de unidades da teoria; e) estipular as leis de interação com a produção de um modelo de interações guiado pelas dez etapas de construção de modelos de causalidade proposto por Jaccard e Jacoby (2010); f) determinação dos limites da teoria; g) especificação dos estados do sistema; h) desenvolvimento das afirmativas axiomáticas; parte 3 i) especificação das proposições da teoria. Resultados: produziu-se a análise do modelo de adaptação de Roy e uma revisão sistemática da literatura sobre fatores de risco para hiperglicemia e hipoglicemia em adultos e idosos com diabetes mellitus em tratamento. Essas estratégias permitiram na análise do construto o desenvolvimento do diagnóstico "Risco de Padrão Glicêmico Desequilibrado no adulto/idoso com Diabetes Mellitus". O processo de teorização determinou as unidades e estados focais, contextuais e residuais da teoria do Risco de Padrão Glicêmico Desequilibrado em adultos e idosocom diabetes mellitus em tratamento. Produziu-se um modelo interativo das unidades focais, nove afirmativas axiomáticas, quatorze proposições teóricas e um modelo representativo da teoria. Conclusões: esta pesquisa elaborou uma teoria de médio alcance, que descreve e explica o Risco de Padrão Glicêmico Desequilibrado, examinando os fatores que influenciam no surgimento da hipoglicemia e hiperglicemia em adultos e idosos com Diabetes Mellitus em tratamento. A presente tese contribui de forma original ao estruturar riscos associados a hipoglicemia e hiperglicemia em um construto de interesse para a enfermagem que pode ter futuros impactos na organização e delimitações de ações do cuidado profissional.
Introduction: the patterns referring to glycemia were not described and explained using a nursing theory as a reference, nor were they articulated and modeled on the predictive structures of interest for nursing action under these conditions. Thus, the relevance of constructing a meddle-range theory that addresses the predisposing and precipitating factors for the variability patterns related to glycemia is presumed, explaining relationships and predicting associations that can support the nursing diagnostic judgment for the population with diabetes mellitus in treatment. Objective: to develop a meddle-range theory on glycemic variations in adults and the elderly with diabetes mellitus undergoing treatment based on Roy's Conceptual Adaptation Model. Method: theoretical research on the type of development of a new theory. For theorizing, Holton and Lowe's (2007) general research process proposal was used. The methodological procedures developed were implemented in three parts: part 1 - a) understanding of the phenomena; b) identification and recovery of studies in the systematic review of etiology and risk and analysis of Roy's adaptation model; c) constructo analysis; part 2 - d) identification of theory units; e) stipulate as laws of interaction with the production of an interaction model guided by the ten stages of construction of causality models addressed by Jaccard and Jacoby (2010); f) determining the limits of the theory; g) replacement of system states; h) development of axiomatic statements; part 3 - i) registration of theory proposals. Results: an analysis of the Roy adaptation model and a systematic review of the literature on risk factors for hyperglycemia and hypoglycemia in adults and the elderly with diabetes mellitus under treatment were carried out. These strategies allowed, in the construct analysis, the development of the diagnosis "Risk of Imbalanced Glycemic Pattern in the adult/ elderly with Diabetes Mellitus". The theorization process determined the focal, contextual and residual units and states of the Imbalanced Glycemic Pattern Risk theory in adults and the elderly with diabetes mellitus being treated. An interactive model of the focal units was produced, nine axiomatic statements, fourteen theoretical propositions and a representative model of the theory. Conclusions: this researcdeveloped a meddle-range theory, which describes and explains the Risk of Imbalanced Glycemic Pattern, examining the factors that influence the appearance of hypoglycemia and hyperglycemia in adults and elderly people with Diabetes Mellitus under treatment. The present thesis contributes in an original way by structuring risks associated with hypoglycemia and hyperglycemia in a construct of interest to nursing that may have future impacts on the organization and delimitations of professional care actions.
Introducción: los patrones que se refieren a la glucemia no se describieron ni explicaron utilizando una teoría de enfermería como referencia, ni se articularon y modelaron sobre las estructuras predictivas de interés para la acción de enfermería en estas condiciones. Por lo tanto, se presume la relevancia de construir una teoría de rango medio que aborde los factores predisponentes y precipitantes para los patrones de variabilidad relacionados con la glucemia, explicando las relaciones y prediciendo asociaciones que pueden apoyar el juicio diagnóstico de enfermería para la población con diabetes mellitus en tratamiento. Objetivo: desarrollar una teoría de rango medio sobre las variaciones glucémicas en adultos y ancianos con diabetes mellitus en tratamiento según el Modelo de Adaptación Conceptual de Roy. Método: investigación teórica como el desarrollo de una nueva teoría. Para la teorización, se utilizó la propuesta del proceso de investigación general de Holton y Lowe's (2007). Los procedimientos metodológicos desarrollados se implementaron en tres partes: parte 1 - a) comprensión de los fenómenos; b) identificación y recuperación de estudios en la revisión sistemática de etiología y riesgo y análisis del modelo de adaptación de Roy; c) análisis de la construcción; parte 2 - d) identificación de unidades teóricas; e) estipular las leyes de interacción con la producción de un modelo de interacción guiado por las diez etapas de construcción de modelos de causalidad propuestos por Jaccard y Jacoby (2010); f) determinar los límites de la teoría; g) especificación de los estados del sistema; h) desarrollo de enunciados axiomáticos; parte 3 - i) especificación de las proposiciones de la teoría. Resultados: se realizó un análisis del modelo de adaptación de Roy y una revisión sistemática de la literatura sobre los factores de riesgo de hiperglucemia e hipoglucemia en adultos y ancianos con diabetes mellitus en tratamiento. Estas estrategias permitieron, en el análisis de la construcción, el desarrollo del diagnóstico "Riesgo de patrón glucémico desequilibrado en adultos / ancianos con diabetes mellitus". El proceso de teorización determinó las unidades y estados focales, contextuales y residuales de la teoría del riesgo de patrón glucémico desequilibrado en adultos y ancianos con diabetes mellitus que se está tratando. Se produjo un modelo interactivo de las unidades focales, nueve declaraciones axiomáticas, catorce proposiciones teóricas y un modelo representativo de la teoría. Conclusiones: esta investigación desarrolló una teoría de rango medio, que describe y explica el riesgo de un patrón glucémico desequilibrado, examinando los factores que influyen en la aparición de hipoglucemia e hiperglucemia en adultos y ancianos con diabetes mellitus bajo tratamiento. La presente tesis contribuye de manera original al estructurar los riesgos asociados con la hipoglucemia y la hiperglucemia en un constructo de interés para la enfermería que puede tener impactos futuros en la organización y delimitaciones de las acciones de atención profesional.
Subject(s)
Humans , Blood Glucose/metabolism , Nursing Diagnosis , Nursing Theory , Diabetes Mellitus/therapy , Hyperglycemia/metabolism , Hypoglycemia/metabolism , Risk Factors , Standardized Nursing TerminologyABSTRACT
Abstract Objective The present study aims to understand to what extent obesity is related to adversematernal, obstetrical, and neonatal outcomes in a Portuguese obstetrical population. Methods A retrospective case-control study was conducted at the Department of Obstetrics of a differentiated perinatal care facility. The study compared 1,183 obese pregnant womenwith 5,399 normal or underweight pregnantwomen for the occurrence of gestational diabetes, hypertensive pregnancy disorders, and preterm birth. Mode of delivery, birthweight, and neonatal intensive care unit (ICU) admissionswere also evaluated. Mean blood glucose values were evaluated and compared between groups, in the first and second trimesters of pregnancy. Only singleton pregnancies were considered. Results The prevalence of obesity was 13.6%. Obese pregnant women were significantly more likely to have cesarean sections (adjusted odds ratio [aOR] 2.0, p< 0.001), gestational diabetes (aOR 2.14, p< 0.001), hypertensive pregnancy disorders (aOR 3.43, p< 0.001), and large-for-gestational age ormacrosomic infants (aOR 2.13, p< 0.001), and less likely to have small-for-gestational age newborns (aOR 0.51, p< 0.009). No significant differences were found in terms of pretermbirths, fetal/neonatal deaths, low birthweight newborns, and neonatal ICU admissions among cases and controls. Maternal obesity was significantly associated with higher mean blood glucose levels, in the first and second trimesters of pregnancy. Conclusion Obesity is associated with increased risks of adverse pregnancy and neonatal outcomes. These risks seem to increase progressively with increasing body mass index (BMI) class. Female obesity should be considered a major public health issue and has consequences on maternal-fetal health.
Resumo Objetivo O presente estudo pretende avaliar em que medida a obesidade influencia os desfechos maternos, obstétricos e neonatais em uma população obstétrica portuguesa. Métodos Um estudo caso-controle retrospectivo foi realizado no departamento de obstetrícia de um centro perinatal diferenciado. O estudo comparou 1.183 grávidas obesas com 5.399 grávidas normoponderais ou com baixo peso para a ocorrência de diabetes gestacional, doenças hipertensivas da gravidez e parto pré-termo. Via de parto, peso ao nascimento e admissão na unidade de cuidados neonatais também foram avaliados. Os valores glicêmicos médios foram avaliados e comparados entre os dois grupos, no primeiro e segundo trimestres de gravidez. Apenas as gravidezes unifetais foram avaliadas. Resultados A prevalência da obesidade foi de 13.6%. As grávidas obesas tiveramrisco significativamente superior a ter uma cesariana (odds ratio ajustado [Ora] 2.0, p < 0.001), diabetes gestacional (ORa 2.14, p < 0.001), doenças hipertensivas da gravidez (ORa 3.43, p < 0.001), recém-nascidos grandes para a idade gestacional ou macrossômicos (ORa 2.13, p < 0.001) e menor probabilidade de ter recém-nascidos pequenos para a idade gestacional (ORa 0.51, p < 0.009). Não houve diferença estatisticamente significativa quanto aos partos pré-termo, mortes fetais/neonatais, baixo peso ao nascer e admissão à unidade de cuidados intensivos neonatais. O odds ratio foi ajustado para a idade, número de gestações, paridade, ganho ponderal, doenças hipertensivas da gravidez e diabetes gestacional. A obesidade materna esteve significativamente associada a valores glicêmicos médios superiores, no primeiro e segundo trimestres de gravidez. Conclusão A obesidade está associada a maior risco de desfechos adversos na gravidez e neonatais. Este risco parece aumentar progressivamente com o aumento do índice de massa corporal (IMC). A obesidade feminina deve ser considerada um importante problema de saúde pública e que tem repercussões na saúde maternofetal.
Subject(s)
Humans , Female , Pregnancy , Adult , Young Adult , Obesity, Maternal/complications , Obesity, Maternal/epidemiology , Portugal/epidemiology , Thinness/epidemiology , Blood Glucose/metabolism , Fetal Macrosomia/epidemiology , Pregnancy Outcome , Case-Control Studies , Comorbidity , Cesarean Section/statistics & numerical data , Prevalence , Retrospective Studies , Diabetes, Gestational/epidemiology , Hypertension, Pregnancy-Induced/epidemiology , Obesity, Maternal/bloodABSTRACT
Abstract Objective To evaluate the factors associated with the need for insulin as a complementary treatment to metformin in pregnant women with gestational diabetes mellitus (GDM). Methods A case-control study was performed from April 2011 to February 2016 with pregnant women with GDM who needed complementary treatments besides diet and physical exercise. Those treated with metformin were compared with those who, in addition to metformin, also needed the combination with insulin. Maternal characteristics and glycemic control were evaluated. Multinomial logistic regression models were developed to evaluate the influence of different therapies on neonatal outcomes. Results A total of 475 pregnant women who needed pharmacological therapy were evaluated. Of these, 366 (77.05%) were submitted to single therapy with metformin, and 109 (22.94%) needed insulin as a complementary treatment. In the analysis of the odds ratio (OR), fasting glucose (FG)<90 mg/dL reduced the odds of needing the combination (OR: 0.438 [0.235-0.815]; p=0.009], as well as primiparity (OR: 0.280 [0.111-0.704]; p=0.007]. In obese pregnant women, an increased chance of needing the combination was observed (OR: 2,072 [1,063-4,039]; p=0,032). Conclusion Obesity resulted in an increased chance of the mother needing insulin as a complementary treatment to metformin, while FG<90 mg/dL and primiparity were protective factors.
Resumo Objetivo Avaliar os fatores associados à necessidade de insulina como tratamento complementar à metformina em gestantes com diabetes mellitus gestacional (DMG). Métodos Um estudo caso-controle foi realizado de abril de 2011 a fevereiro de 2016 comgestantes portadoras de DMG que necessitaram de tratamentos complementares além de dieta e exercícios físicos. Aquelas tratadas commetformina foram comparadas com aquelas que, além da metformina, também precisaram de combinação com insulina. Foram avaliadas as características maternas e de controle glicêmico. Modelos de regressão logística multinomial foram construídos para avaliar a influência das diferentes terapias nos desfechos neonatais. Resultados Foram avaliadas 475 gestantes que necessitaram de terapia farmacológica. Destas, 366 (77,05%) utilizaram terapia única com metformina, e 109 (22,95%) necessitaram de insulina como tratamento complementar. Na análise da razão de possibilidades (RP), a glicemia de jejum (GJ)<90mg/dL reduziu as chances de necessidade da combinação (RP: 0,438 [0,235-0,815]; p=0,009), bem como a primiparidade (RP: 0,280 [0,111-0,704]; p=0,007). Em gestantes obesas, foi observada uma chance maior de necessidade da combinação (RP: 2.072 [1.063-4.039]; p=0,032). Conclusão A obesidade resultou em um aumento na chance de a mãe precisar de insulina como tratamento complementar à metformina, enquanto a GJ<90 mg/dL e a primiparidade foram fatores de proteção.
Subject(s)
Humans , Female , Pregnancy , Adult , Diabetes, Gestational/drug therapy , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Metformin/therapeutic use , Parity , Blood Glucose/metabolism , Case-Control Studies , Diabetes, Gestational/diet therapy , Diabetes, Gestational/blood , Drug Therapy, Combination , Exercise Therapy , Obesity, Maternal/complications , Obesity, Maternal/diet therapy , Obesity, Maternal/bloodABSTRACT
Abstract Background: Metabolic syndrome is a cluster of metabolic abnormalities and abdominal obesity; its pathophysiologic basis, insulin resistance, has been shown to act as agent in thyroid cell proliferation. Few studies analyze the relationship between metabolic syndrome and thyroid nodular disease, with a substantial knowledge gap. Objective: Determine the association between metabolic syndrome and nodular thyroid disease in a region with adequate iodine intake. Methods: Case-control study. A total of 182 patients referred to radiology to undergo thyroid ultrasonography due to suspicion of thyroid disease. Cases had at least one thyroid nodule greater than 3 mm (n= 91). Controls did not have evidence of thyroid nodules (n= 91). Results: Bivariate analysis showed a significant association between metabolic syndrome and the presence of thyroid nodule (OR 2.56, 95% CI: 1.41-4.66, p <0.05). Low levels of HDL (OR 2.81, 95% CI: 1.54-5.12, p <0.05) and impaired fasting glucose (OR 2.05, 95%CI 1.10 to 3.78, p <0.05) were significantly associated with the presence of thyroid nodule, independent of the presence of metabolic syndrome. Multivariate analysis maintained the association between metabolic syndrome and thyroid nodule with an OR of 2.96 (95%CI 1.47 to 5.95, p <0.05); similarly, the associations of low levels of HDL (OR 2.77, 95%CI 1.44 to 5.3, p <0.05) and impaired fasting glucose (OR 2.23, 95%CI 1.14 to 4.34, p<0.05) with thyroid nodule remained significant. Conclusion: The thyroid nodular disease is associated with increased risk of metabolic syndrome, specifically decreased HDL and impaired fasting glucose levels were the factors that increased association was found.
Resumen Antecedentes: el síndrome metabólico es un conjunto de anormalidades metabólicas y obesidad abdominal; Se ha demostrado que su base fisiopatológica, la resistencia a la insulina, actúa como agente en la proliferación de las células tiroideas. Pocos estudios analizan la relación entre el síndrome metabólico y la enfermedad nodular tiroidea, con una brecha de conocimiento sustancial. Objetivo: determinar la asociación entre el síndrome metabólico y la enfermedad tiroidea nodular en una región con una ingesta adecuada de yodo. Métodos: estudio de casos y controles. Un total de 182 pacientes remitidos a radiología para someterse a una ecografía tiroidea debido a la sospecha de enfermedad tiroidea. Los casos tenían al menos un nódulo tiroideo mayor de 3 mm (n = 91). Los controles no tenían evidencia de nódulos tiroideos (n = 91). Resultados: El análisis bivariado mostró una asociación significativa entre el síndrome metabólico y la presencia de nódulo tiroideo (OR 2.56, IC 95%: 1.41-4.66, p <0.05). Los niveles bajos de HDL (OR 2.81, IC 95%: 1.54-5.12, p <0.05) y glucosa en ayunas alterada (OR 2.05, IC 95% 1.10 a 3.78, p <0.05) se asociaron significativamente con la presencia de nódulo tiroideo, independiente de la presencia de síndrome metabólico. El análisis multivariado mantuvo la asociación entre el síndrome metabólico y el nódulo tiroideo con un OR de 2.96 (IC 95% 1.47 a 5.95, p <0.05); de manera similar, las asociaciones de niveles bajos de HDL (OR 2.77, IC 95% 1.44 a 5.3, p <0.05) y glucosa en ayunas alterada (OR 2.23, IC 95% 1.14 a 4.34, p <0.05) con nódulo tiroideo permanecieron significativas. Conclusión: la enfermedad nodular tiroidea se asocia con un mayor riesgo de síndrome metabólico, específicamente la disminución de HDL y los niveles de glucosa en ayunas alterados fueron los factores que aumentaron la asociación.
Subject(s)
Adult , Female , Humans , Male , Middle Aged , Thyroid Nodule/epidemiology , Metabolic Syndrome/epidemiology , Goiter, Nodular/epidemiology , Blood Glucose/metabolism , Case-Control Studies , Cholesterol, HDL/bloodABSTRACT
ABSTRACT BACKGROUND: Obese adolescents are at higher risk of development of cardiovascular risk factors and obesity in later life. Dietary intake of antioxidants, particularly curcumin, as an active ingredient of turmeric extract, may have noticeable effects on obesity and its important complications such as cardiovascular risk factors. Therefore, the aim of this study was to assess the effects of curcumin supplementation on cardiovascular risk factors among overweight and obese female adolescents. DESIGN AND SETTING: Randomized placebo-controlled clinical trial; Pediatric Cardiovascular Research Center, Isfahan, Iran. METHODS: 60 adolescent girls (aged 13-18 years) were randomly assigned to receive either placebo or intervention. The adolescents were asked to consume one 500 mg tablet per day, containing either standardized 95% turmeric extract or placebo, and to undergo a weight maintenance or a mild weight loss diet for 10 weeks. Anthropometric and biochemical indices were assessed at the baseline and the end of the intervention. RESULTS: Curcumin supplementation had beneficial effects on body mass index (P = 0.019), waist circumference (P = 0.008), hip circumference (P = 0.030), high-density lipoprotein levels (P = 0.042) and triglyceride/high-density lipoprotein ratio (P = 0.021). However, in univariate analysis of covariance, no significant differences were found between the intervention and placebo groups after 10 weeks of supplementation (P > 0.05). CONCLUSIONS: Prescription of curcumin supplementation along with use of a slight weight loss diet might have beneficial effects on some cardiovascular risk factors among overweight and obese female adolescents. Larger clinical trials with higher curcumin doses and longer duration are needed to confirm the results from the current study. CLINICAL TRIAL REGISTRATION: IRCT20171107037302N1
Subject(s)
Humans , Female , Adolescent , Body Composition/drug effects , Cardiovascular Diseases/etiology , Cardiovascular System/drug effects , Curcumin/administration & dosage , Overweight/metabolism , Blood Glucose/metabolism , Blood Pressure/drug effects , Exercise/physiology , Body Mass Index , Risk Factors , Dietary Supplements/analysis , Diet, Reducing , Waist Circumference , Lipids/blood , Obesity/complications , Obesity/metabolismABSTRACT
ABSTRACT Objective We investigated the utility of maternal fetuin-A, N-terminal proatrial natriuretic peptide (pro-ANP), high-sensitivity C-reactive protein (hs-CRP), and fasting glucose levels at 11-14 gestation weeks for predicting pregnancies complicated by gestational diabetes mellitus (GDM). Subjects and methods This prospective cohort study included 327 low-risk pregnant women who completed antenatal follow-up at a tertiary research hospital between January and April 2014. Maternal blood samples were collected between 11-14 gestational weeks in the first trimester of pregnancy and then stored at -80 °C until further analyses. During follow-up, 29 (8.8%) women developed GDM. The study population was compared 1:2 with age- and body mass index-matched pregnant women who did not develop GDM (n = 59). Fasting plasma glucose (FPG) levels and serum fetuin-A, pro-ANP, and hs-CRP levels were measured using automated immunoassay systems. Results There was a significant negative correlation between fetuin-A and hs-CRP (CC = -0.21, p = 0.047) and a positive correlation between FPG and hs-CRP (CC = 0.251, p = 0.018). The areas under the receiver operating characteristic curve for diagnosing GDM were 0.337 (p = 0.013), 0.702 (p = 0.002), and 0.738 (p < 0.001) for fetuin-A, hs-CRP, and FPG, respectively. The optimal cut-off values were > 4.65, < 166, and > 88.5 mg/dL for maternal hs-CRP, fetuin-A, and FPG, respectively. Conclusion Reduced fetuin-A, elevated hs-CRP, and FPG levels in women in the first trimester can be used for the early detection of GDM. Further research is needed before accepting these biomarkers as valid screening tests for GDM.
Subject(s)
Humans , Female , Pregnancy , Adolescent , Adult , Young Adult , Pregnancy Trimester, First/blood , Blood Glucose/metabolism , C-Reactive Protein/metabolism , Insulin Resistance , Decision Support Techniques , Diabetes, Gestational/diagnosis , Insulin/blood , Biomarkers/blood , Logistic Models , Odds Ratio , Predictive Value of Tests , Retrospective Studies , Follow-Up Studies , Sensitivity and Specificity , Diabetes, Gestational/bloodABSTRACT
Resumo O objetivo deste estudo foi determinar e comparar a magnitude da associação entre indicadores antropométricos com fatores de risco cardiometabólico em idosos. Trata-se de estudo transversal com 402 idosos atendidos pela Estratégia Saúde da Família no município de Viçosa-MG. Os fatores de risco considerados foram o excesso de gordura corporal, hipertensão arterial, alteração da glicemia e dos lipídeos séricos. A associação entre o índice de conicidade (IC) e a relação cintura/estatura (RCE) com os fatores de risco cardiometabólico foi avaliada pela análise de regressão linear múltipla. A amostra foi composta por 60,4% de mulheres e 36,3% de idosos com excesso de peso. O índice de conicidade e a relação cintura/estatura estiveram elevados em 57,2% e 88,1% dos idosos, respectivamente. Os resultados demonstraram que o aumento da gordura corporal, da pressão arterial diastólica, dos triglicerídeos, da glicemia e a redução do HDL-colesterol estão relacionados a maiores valores dos índices antropométricos avaliados. No entanto, a relação cintura/estatura apresentou maior magnitude de associação com os fatores de risco cardiometabólico do que o índice de conicidade.
Abstract The purpose of this study was to determine and compare a magnitude of the association between anthropometric indicators with risk of cardiometabolic risk in the elderly. This is a cross-sectional study with 402 elderly people attended by the Family Health Strategy in the city of Viçosa-MG. Risk factors for excess body fat, hypertension, blood glucose and serum lipid changes. An association between conicity index (CI) and waist-to-height ratio (WtHR) with cardiometabolic risk factors was assessed by multiple linear regression analysis. Sample was composed of 60.4% of women and 36.3% of overweight elderly. The connectivity index and a waist-to-height ratio were higher in 57.2% and 88.1% in the elderly, respectively. The results showed that the increase in body fat, diastolic blood pressure, triglycerides, glycemia and reduction of HDL-cholesterol are related to higher values of anthropometric indices evaluated. However, the waist-to-height ratio presented a greater magnitude of association with the cardiometabolic risk factors than the connectivity index.
Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Cardiovascular Diseases/epidemiology , Waist-Height Ratio , Metabolic Diseases/epidemiology , Blood Glucose/metabolism , Cardiovascular Diseases/etiology , Adipose Tissue , Cross-Sectional Studies , Risk Factors , Overweight/epidemiology , Hypertension/epidemiology , Lipids/blood , Metabolic Diseases/etiology , Middle AgedABSTRACT
Abstract Background Irisin is a protein cleaved from fibronectin type III domain-containing protein 5 and has been implicated in the beneficial effects of exercise. However, it is unknown which factors contribute to irisin increment after intensive exercising in humans. This study aimed to assess independent factors related with serum irisin after 2 weeks of supervised physical activity in young sedentary healthy women. Design and Methods We developed a comparative, interventional, longitudinal, and prospective study at a third-level specialty health center. Between March 2010 and August 2011, 82 sedentary young adult women, without chronic diseases or regular medical treatments, were recruited. A total of 38 women fulfilled selection criteria, and irisin concentrations were quantified before and after the intervention. Independent factors related with irisin increment were evaluated according to mild to moderate and vigorous intensity of physical activity. A supervised treadmill exercise test following the Bruces protocol was conducted from Monday to Friday during 2 weeks. In addition, anthropometric measurements were taken, and fibroblast growth factor 21 (FGF21), glucose, insulin, and liver transaminases were measured. Results Intensity of exercising was directly related to irisin (p = 0.02) and FGF21 (p = 0.01) serum levels. However, an independent and significant relationship between FGF21 and irisin was not confirmed. A novel association was found between alanine aminotransferase (ALT) and irisin, showing a positive and significant correlation (r = 0.37, p = 0.02). The association was particularly strong with higher intensity of aerobic exercising (r = 0.64, p = 0.01). Linear regression model adjusted for glucose and body mass index confirmed an independent association between ALT and irisin and also between insulin and irisin (adjusted R² = 0.12, p = 0.04). Such association increased after grouping in moderate to vigorous physical activity intensity (adjusted R² = 0.46, F = 4.7, p = 0.03). Conclusions Serum irisin and FGF21 levels significantly increased after 2 weeks of supervised physical activity. However, only fasting insulin and ALT, but not FGF21, were independent parameters explaining irisin increment, mainly after moderate to vigorous exercising.